November 28, 2016 - By Pete Kolinski · 0 Comments
The stock of BIOSTEM TECH INCORPORATED (OTCMKTS:BSEM) registered an increase of 33.33% in short interest. BSEM’s total short interest was 1,200 shares in November as published by FINRA. Its up 33.33% from 900 shares, reported previously. With 1,600 shares average volume, it will take short sellers 1 days to cover their BSEM’s short positions. The stock last traded at $12.5 per share. It is down 21.12% since April 25, 2016 and is uptrending. It has outperformed by 15.11% the S&P500.
Biostem Technologies, Inc., incorporated on February 12, 2009, is a development-stage company. The Firm is a biotechnology firm focused on the development of anti-aging nutraceutical and cosmeceutical products, stem cell therapies, pharmaceuticals and educational well-known provider of cell treatment protocols. The Company’s divisions include Biostem Cell Therapy, Biostem Pharmaceuticals and Biostem Wellness. Biostem Cell Therapy provides stem cell therapies, stem cell banking, stem cell therapy, and stem cell research and development. Biostem Pharmaceuticals provides research and product development, active pharmaceutical ingredient (API) re-packaging and lab services. Biostem Wellness provides anti-aging and rejuvenation services and products, wellness and management programs, among others.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Pete Kolinski